In the quest for increased sustainability, a lot has been made of the potential to use bio-based raw materials, captured CO2 and recycled plastics as raw materials for new chemicals. But what about using biotech processes to manufacture chemicals? Could it offer a more sustainable alternative to traditional petrochemical processing, and be more amenable to biobased raw materials?

It’s something companies both large and small are investigating. Covestro, for example, has a pilot plant at its headquarters site in Leverkusen, Germany, making aniline from biomass via a fermentation process. This basic chemical is typically manufactured from naphtha; the fermentation requires much milder conditions, and the intermediate isolated from the fermentation is then transformed to aniline via a catalytic reaction.

BASF, meanwhile, has been working on industrial biotechnology for more than three decades, first for the animal feed enzyme phytase, and then shifting vitamin B2 production from a chemical to a biotech process more than 20 years ago.

It is now possible to rewire the cellular metabolism to use unconventional raw material streams to produce interesting molecules.

Outsourcing to a CMO in the early stages is vital for start-ups looking to make chemical products via fermentation, as they are unlikely to have the resources to build their own production capacity before they have proved viability. It allows the concept to be proved before the cash is spent.

Michele Stansfield, co-founder and chief executive at Australia-based Cauldron Ferm, believes the fact that biomanufacturing can be optimised for a wide range of resource-efficient products make it a promising alternative to petrochemical-based manufacturing. ‘A key advantage of using fermentation to produce chemicals is reducing the reliance on non-renewable fossil fuels,’ she says. ‘Fermentation also presents a safe, lower energy consumption alternative. Unlike many chemical manufacturing processes that require high heat or pressure, fermentation typically operates at lower temperatures and pressures. Biomanufacturing also allows for the manufacture of complex biomolecules such as proteins, which are not readily made by chemical synthesis processes.’

Reference:

Biomanufacturing proliferates in chemicals | Business | Chemistry World

READ MORE
Exim rebrands as ExSyn: We celebrate our 30-year heritage with a new brand and website that bring alive our values and purpose
News · 27/03/2021

Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.

In focus: N,N′-Dimethylethylenediamine   
Products in focus · 10/11/2026

N,N′-Dimethylethylenediamine (DMEDA) is an organic chemical compound belonging to the diamine family. It contains two nitrogen atoms, each bearing a methyl group, connected by a two-carbon chain.

Global Freight Costs Surge 130%
News · 03/11/2026

Global shipping costs have climbed to $4,000–$4,500 in October from $2,000–$2,500 in February 2026. Freight rates, which had eased through much of 2025 and early 2026 as the demand-supply balance improved, have rebounded sharply in recent months. The increase has brought shipping costs back into focus for businesses dependent on international cargo movement.

FDA Issues Final Guidance on Manufacturing Changes for Biosimilars
News · 03/11/2026

The U.S. Food and Drug Administration (FDA) has finalized guidance outlining how manufacturers should report post-approval manufacturing changes for biosimilar and interchangeable biosimilar products. The guidance provides greater regulatory clarity on changes involving production processes, manufacturing sites, analytical methods, raw materials, and process controls. It aims to ensure product quality while reducing unnecessary regulatory burden.